Other substances

YKYRYL peptide

A SARS-CoV-2 spike protein RBD fragment.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

YKYRYL peptide is a fragment of the SARS-CoV-2 spike protein RBD with predicted high binding affinity to RBD itself (Peter et al., 2020).

 

YKYRYL

Supporting references

Link Tested on Impact factor Notes Publication date
The Inhibitory Effect of a Coronavirus Spike Protein Fragment with ACE2
Spike protein ACE2 Peptide In silico 		in silico 3.85

Predicted to bind to the SARS-CoV-2 spike protein RBD and thereby inhibit ist interaction with the host's ACE2.

 Aug/27/2020
Export (.csv)